# Cancer Control Research Program (CC)

> **NIH NIH P30** · OHIO STATE UNIVERSITY · 2020 · $299,186

## Abstract

PROJECT-001: CANCER CONTROL PROGRAM (CC) 
PROJECT SUMMARY / ABSTRACT 
The Cancer Control (CC) Program at the Ohio State University Comprehensive Cancer Center (OSUCCC), led 
by Electra D. Paskett, PhD, MSPH and Mary Ellen Wewers, RN, PHD, MPH, has 52 members from 19 OSU 
departments within the OSU Colleges of Medicine, Public Health, Arts and Sciences, Law, Nursing, Education 
and Human Ecology, Dentistry, and Food, Agricultural and Environmental Sciences, as well as Nationwide 
Children's Hospital and Cincinnati Children's Hospital. Program members provide a wealth of behavioral, 
basic, clinical, policy, outcomes, and social scientific knowledge and expertise not only to the CC Program, but 
to the OSUCCC as a whole. The overall CC Program goal is to conduct research to reduce the incidence, 
mortality and morbidity of cancer, which is accomplished by employing a transdisciplinary research team 
approach. The Specific Aims of the CC Program are to: 1) Identify molecular, genetic, and behavioral factors 
related to cancer incidence and mortality; 2) Develop and test behavioral interventions to prevent or detect 
cancer early; and, 3) Assess and intervene on issues of cancer survivorship. An additional developing aim of 
the CC Program is to address policy in relation to cancer prevention, detection, and care. Within these aims, 
research focuses on cross-cutting themes including underserved/minority populations within our catchment 
area, communication research, tobacco use and toxicity (including regulatory science), and behavioral 
strategies that capitalize on our members' strengths, such as epidemiology, biology and behavior. The 
program now has 2 NCI P50-funded Centers, both showcasing not only our multi-level focus but also the 
transition from observational to interventional studies. In addition, many of our interventions, e.g., Patient 
Navigation and Bio-Behavioral Intervention to Reduce Stress after Breast Cancer, have been incorporated into 
clinical care. Moreover, our research has contributed to policy changes, most notably the establishment of a 
smoke-free campus at OSU. During this past funding period (2009 - 2014), the Program members published a 
total 611 articles in peer-reviewed journals of which 32% have intra-programmatic collaboration, 20% have 
inter-programmatic collaborations, and 404 (66%) of the publications represent multi-institutional 
collaborations. Many of these publications fall within each of these categories bringing the total collaborative 
publications to 85%. CC Program funding stands at $6.8M of which $6.2M is peer-reviewed funding and of 
that, $3.9M (63%) is NCI funding. CC Program investigators have enrolled 9,205 participants to research 
studies over the last 5 years, 64% to externally peer-reviewed studies and 34% to institutional studies, 1.2% to 
cooperative trial group studies and 0.8% to industry studies. Of these, 6,964 (76%) were enrolled on 
interventional studies and 2,241 (24%) on non-int...

## Key facts

- **NIH application ID:** 10240807
- **Project number:** 3P30CA016058-44S3
- **Recipient organization:** OHIO STATE UNIVERSITY
- **Principal Investigator:** ELECTRA D. PASKETT
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $299,186
- **Award type:** 3
- **Project period:** 1997-09-12 → 2020-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10240807

## Citation

> US National Institutes of Health, RePORTER application 10240807, Cancer Control Research Program (CC) (3P30CA016058-44S3). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10240807. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*